Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell CarcinomaJenny Bulgarelli, Laura Ridolfi|Frontiers in Immunology|2021Cited by 23
The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population‐based investigation*Federica Zamagni, Stefano Ferretti, Annibale Biggeri et al.|British Journal of Dermatology|2022Cited by 21
The descriptive epidemiology of melanoma in Italy has changed - for the betterLauro Bucchi, Fabio Falcini, Silvia Mancini et al.|Italian Journal of Dermatology and Venereology|2023Cited by 5